Association of CD32-131H>R Polymorphism with End-Stage Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases
Journal of Innate Immunity · 25.05.2026 · 18 (1) · 311-314
DOI: 10.1159/000552727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, online erschienen am 25.05.2026. Verfasst von Sarah M Berger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Virology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Receptors, IgG, Lung Diseases, Interstitial. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Introduction
Progression to end-stage lung diseases is influenced by both environmental and genetic factors, yet predictive markers remain limited. The CD32-131H>R polymorphism in the FCGR2A gene alters the affinity of the FcγRIIa receptor for IgG and may impair immune clearance, potentially influencing immune responses involved in chronic lung disease. In our study, we investigated the association between the CD32-131H>R polymorphism and end-stage pulmonary diseases requiring LTX.
Methods
The CD32-131H>R polymorphism was determined in 985 lung transplant recipients and 2,116 matched controls via TaqMan genotyping assays.
Results
The low-affinity CD32-131R allele was significantly more prevalent among lung transplant recipients with chronic obstructive pulmonary disease (COPD) and interstitial lung diseases (ILD) compared to controls (p < 0.0001 and p = 0.01, respectively).
Conclusion
Our study demonstrates that the CD32-131R allele is enriched among patients with end-stage COPD and ILD requiring LTX, highlighting a possible association between Fcγ receptor-mediated immune responses and end-stage pulmonary disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Virology, Medical University of Vienna, Vienna, Austria.
- Department of Internal Medicine, Franziskus Spital Margareten, Vienna, Austria.
- Division of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
- Center for Virology, Medical University of Vienna, Vienna, Austria, hannes.vietzen@meduniwien.ac.at.
Zitieren
APA
Berger, S. M., Kühner, L. M., Schwarzinger, I. M., Heiss Spornberger, V., Jaksch, P., Puchhammer-Stöckl, E., & Vietzen, H. (2026). Association of CD32-131H>R Polymorphism with End-Stage Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases. Journal of Innate Immunity, 18(1), 311-314. https://doi.org/10.1159/000552727
Vancouver
Berger SM, Kühner LM, Schwarzinger IM, Heiss Spornberger V, Jaksch P, Puchhammer-Stöckl E, et al. Association of CD32-131H>R Polymorphism with End-Stage Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases. Journal of Innate Immunity. 2026;18(1):311-314. doi:10.1159/000552727
BibTeX
@article{Berger2026,
author = {Berger, Sarah M and Kühner, Laura M and Schwarzinger, Ines M and Heiss Spornberger, Verena and Jaksch, Peter and Puchhammer-Stöckl, Elisabeth and Vietzen, Hannes},
title = {Association of CD32-131H>R Polymorphism with End-Stage Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases},
journal = {Journal of Innate Immunity},
year = {2026},
volume = {18},
number = {1},
pages = {311--314},
doi = {10.1159/000552727}
}
EUVIMED